CINA CHEST vs AVIEW Lung Nodule CAD
AI Verdict
Choose CINA CHEST if…
Choose CINA CHEST if your primary need is rapid, AI-powered triage and immediate notification for acute, life-threatening chest conditions like Pulmonary Embolism or Aortic Dissection in an emergency setting. This tool is ideal for accelerating the identification and prioritization of critical cases on CT angiography scans to optimize emergency workflow.
View CINA CHEST →Choose AVIEW Lung Nodule CAD if…
Choose AVIEW Lung Nodule CAD if your focus is on comprehensive lung cancer screening, detailed nodule management, and quantitative assessment of chronic lung diseases and cardiovascular risk. This software excels at precise nodule detection, classification, volume quantification, and tracking over time, while also providing simultaneous analysis for emphysema and coronary artery calcification.
View AVIEW Lung Nodule CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA CHEST | AVIEW Lung Nodule CAD |
|---|---|---|
| Pricing | Subscription-based | Unknown |
| Deployment | Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker) | On-premises and cloud environment |
| FDA Status | K210237 AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CINA CHESTTool A (CINA CHEST) emphasizes seamless integration into existing clinical workflows, aiming for 'zero disruption' and 'no additional clicks, training, or workflow changes' by integrating natively with PACS and RIS. This approach, which makes the AI 'invisible to end users,' suggests a highly intuitive and non-intrusive user experience.
Clinical Value
CINA CHESTWhile both tools offer significant clinical value, Tool A (CINA CHEST) focuses on the rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD) in emergency radiology. Its ability to provide real-time alerts for these acute conditions directly impacts urgent patient intervention and survival rates.
Pricing & Value
CINA CHESTBoth tools lack public pricing transparency. However, Tool A (CINA CHEST) explicitly states a 'subscription-based' pricing model, with details available upon request and based on the number of analyses or installations. Tool B (AVIEW Lung Nodule CAD) is transitioning to a subscription model but also mentions a CapEx model in some markets, indicating less consistent pricing clarity.
Enterprise Readiness
AVIEW Lung Nodule CADBoth tools offer flexible deployment options and HIPAA compliance. Tool B (AVIEW Lung Nodule CAD) demonstrates strong enterprise readiness through its proven solution across 19 countries, processing over 2.5 million cases globally, and holding 11 FDA clearances. This extensive real-world adoption and regulatory maturity indicate robust capabilities for large-scale enterprise deployment and management.
Innovation
AVIEW Lung Nodule CADBoth utilize AI, but Tool B (AVIEW Lung Nodule CAD) stands out with its 'Big 3' simultaneous analysis of lung nodules, emphysema, and coronary artery calcification from a single CT scan. This comprehensive, multi-disease approach, coupled with nodule tracking and volume doubling time calculation, represents a broader and more integrated diagnostic innovation for chronic disease screening and management.
Support & Docs
TieNeither tool provides extensive public information regarding comprehensive customer support channels, service level agreements, or detailed training programs. Tool A mentions 'Instructions for Use are available here', and Tool B refers to 'catalogs' and a general 'Contact us' for inquiries. Based on the available data, there is insufficient information to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA CHEST | AVIEW Lung Nodule CAD |
|---|---|---|
| Product Name | CINA CHEST | AVIEW Lung Nodule CAD |
| Company | Avicenna.AI | Coreline Soft Co. |
| Primary Function | AI-powered radiological triage and notification software for rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | AI-powered software that assists radiologists in detecting and analyzing pulmonary nodules on chest CT scans, and offers comprehensive screening for lung cancer, COPD, and coronary artery calcification. |
| Key Detections/Conditions Analyzed | Pulmonary Embolism (PE), Aortic Dissection (AD) | Pulmonary nodules (3-20 mm), Emphysema, Coronary Artery Calcification (CAC) |
| Specialties Supported | Cardiology, Emergency Medicine, Radiology | Cardiology, Pulmonology, Radiology |
| Specific AI Capabilities | Radiological computer-aided triage and notification; Flags and communicates suspected positive findings; Utilizes artificial intelligence (deep learning algorithms) | AI-based pulmonary nodule detection; Nodule classification (solid, part-solid, non-solid); 3D nodule size and volume quantification; Automatic report generation based on Lung-RADS classification; Nodule matching and volume doubling time (VDT) calculation; Quantitative emphysema analysis; Coronary Artery Calcification (CAC) scoring |
Videos
Demos, reviews, and walkthroughs featuring CINA CHEST and AVIEW Lung Nodule CAD.